Literature DB >> 2879593

The effects of alfentanil and selected narcotic analgesics on the rate of action potential discharge of medullary respiratory neurones in anaesthetized rats.

K C Fone, H Wilson.   

Abstract

The effects of intravenous injections of alfentanil, fentanyl, phenoperidine or morphine on respiratory and peak inspiratory air flow rate, the diaphragm electromyogram (EMG), the activity recorded extracellularly from respiratory neurones located in the ventral respiratory group and the cardiovascular system were examined in anaesthetized rats. Alfentanil produced dose-dependent changes in peripheral and central respiratory parameters, which were prevented by naloxone pretreatment. Minimal effects were produced on the cardiovascular system. The bradypnoea was principally due to a prolongation of the inspiratory phase and was accompanied by a comparable decrease in the peak inspiratory air flow rate. Alfentanil prolonged the discharge duration of inspiratory neurones such that it still maintained a strict phase correlation with the diaphragm EMG, but changes in firing frequency were inconsistent and negligible. The action on expiratory neuronal discharge was analogous to that on inspiratory neuronal discharge but delayed in onset. Hypotension produced by morphine limited the dose used but the respiratory responses to morphine and other selected narcotic analgesics were otherwise similar to that of alfentanil, differing mainly in time-course and magnitude. From the respiratory parameters assessed, the order of duration of effect was morphine greater than phenoperidine greater than fentanyl greater than alfentanil and the relative potencies were 0.1, 0.5, 2.5 and 1 respectively. The selective prolongation of inspiration and the immediate action on inspiratory neurones suggests that systemically administered narcotic analgesics may alter the mechanisms within the central respiratory rhythm generator which determine the cessation of inspiration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2879593      PMCID: PMC1917050          DOI: 10.1111/j.1476-5381.1986.tb11121.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Interaction of respiratory cell discharge patterns and spontaneous resporatory rate.

Authors:  C L Webber; C N Peiss
Journal:  Am J Physiol       Date:  1975-05

2.  Effects of morphine and meperidine on the central respiratory mechanisms in the cat; the action of levallorphan in antagonizing these effects.

Authors:  S H NGAI
Journal:  J Pharmacol Exp Ther       Date:  1961-01       Impact factor: 4.030

3.  Single unit activity in medullary respiratory centers of cat.

Authors:  J R NELSON
Journal:  J Neurophysiol       Date:  1959-09       Impact factor: 2.714

4.  Neurogenesis of respiratory rhythm in the mammal.

Authors:  M I Cohen
Journal:  Physiol Rev       Date:  1979-10       Impact factor: 37.312

5.  Effects of opiates and methionine-enkephalin on pontine and bulbar respiratory neurones of the cat.

Authors:  M Denavit-Saubié; J Champagnat; W Zieglgänsberger
Journal:  Brain Res       Date:  1978-10-20       Impact factor: 3.252

6.  Location and function of medullary respiratory neurons.

Authors:  R A Mitchell
Journal:  Am Rev Respir Dis       Date:  1977-06

7.  A comparative study in the cat of the respiratory effects of morphine injected intravenously and into the cerebrospinal fluid.

Authors:  J Flórez; L E McCarthy; H L Borison
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

8.  Pharmacological identification of delta and mu opiate receptors on bulbar respiratory neurons.

Authors:  M P Morin-Surun; G Gacel; J Champagnat; M Denavit-Saubie; B P Roques
Journal:  Eur J Pharmacol       Date:  1984-02-17       Impact factor: 4.432

9.  Cardiovascular and some respiratory effects of high doses of alfentanil in dogs.

Authors:  J D'Aubioul; W Van Gerven; A Van de Water; R Xhonneux; R S Reneman
Journal:  Eur J Pharmacol       Date:  1984-04-13       Impact factor: 4.432

10.  Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors.

Authors:  A I Faden; G Feuerstein
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

View more
  5 in total

1.  Oscillation patterns are enhanced and firing threshold is lowered in medullary respiratory neuron discharges by threshold doses of a μ-opioid receptor agonist.

Authors:  Peter M Lalley; Steve W Mifflin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-02-15       Impact factor: 3.619

2.  CrossTalk opposing view: The pre-Botzinger complex is not essential for respiratory depression following systemic administration of opioid analgesics.

Authors:  Peter M Lalley; Paul M Pilowsky; Hubert V Forster; Edward J Zuperku
Journal:  J Physiol       Date:  2014-03-15       Impact factor: 5.182

3.  S-Nitroso-L-Cysteine Stereoselectively Blunts the Deleterious Effects of Fentanyl on Breathing While Augmenting Antinociception in Freely-Moving Rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Ryan B Gruber; Benjamin Gaston; Tristan H J Lewis; Alan Grossfield; James M Seckler; Yee-Hsee Hsieh; James N Bates; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

4.  D-Cysteine Ethyl Ester Reverses the Deleterious Effects of Morphine on Breathing and Arterial Blood-Gas Chemistry in Freely-Moving Rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Walter J May; Alex P Young; Benjamin Gaston; Matthew R Hodges; Hubert V Forster; James N Bates; Christopher G Wilson; Tristan H J Lewis; Yee-Hee Hsieh; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

5.  L-cysteine methyl ester overcomes the deleterious effects of morphine on ventilatory parameters and arterial blood-gas chemistry in unanesthetized rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Walter J May; James N Bates; Christopher R Ellis; Michael G Feasel; Christopher G Wilson; Tristan H J Lewis; Benjamin Gaston; Yee-Hsee Hsieh; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-09-28       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.